80 related articles for article (PubMed ID: 2282971)
1. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
[TBL] [Abstract][Full Text] [Related]
2. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
Grimm H
Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Kitzis MD; Ferré B; Coutrot A; Acar JF; Gutmann L
Eur J Clin Microbiol Infect Dis; 1989 Sep; 8(9):783-8. PubMed ID: 2556277
[TBL] [Abstract][Full Text] [Related]
4. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
5. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Grace ME; Fu KP; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
[TBL] [Abstract][Full Text] [Related]
6. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
Moosdeen F; Keeble J; Williams JD
Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
[TBL] [Abstract][Full Text] [Related]
7. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
[TBL] [Abstract][Full Text] [Related]
8. Overcoming enzymatic resistance in bacteria: impact on future therapy.
Labia R; Barthélémy M; Péduzzi J; Morand A; Tiwari K; Kazmierczak A
J Int Med Res; 1990; 18 Suppl 4():48D-57D. PubMed ID: 2282969
[TBL] [Abstract][Full Text] [Related]
9. The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
Farmer TH; Reading C
J Chemother; 1989 Jul; 1(4 Suppl):331-3. PubMed ID: 16312426
[No Abstract] [Full Text] [Related]
10. Evolution of beta-lactamase inhibitors.
Jackson D
Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
[TBL] [Abstract][Full Text] [Related]
11. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
[TBL] [Abstract][Full Text] [Related]
12. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
Moosdeen F; Williams J; Yamabe S
Chemioterapia; 1987 Jun; 6(2 Suppl):206-7. PubMed ID: 2855613
[No Abstract] [Full Text] [Related]
13. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates.
Perilli M; Felici A; Oratore A; Cornaglia G; Bonfiglio G; Rossolini GM; Amicosante G
Antimicrob Agents Chemother; 1996 Mar; 40(3):715-9. PubMed ID: 8851599
[TBL] [Abstract][Full Text] [Related]
15. Implications of beta-lactamase-inhibitor combinations.
Fuchs PC; Barry AL
J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
[TBL] [Abstract][Full Text] [Related]
16. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP
Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
[TBL] [Abstract][Full Text] [Related]
17. [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].
Aubert G; Peyle V; Dumont N; el Fassi M; Dorche G
Ann Biol Clin (Paris); 1990; 48(7):449-54. PubMed ID: 2278408
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
Moittie D; Simonet M; Veron M
Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
[TBL] [Abstract][Full Text] [Related]
19. The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis.
Farmer TH; Reading C
J Antimicrob Chemother; 1988 Aug; 22(2):105-11. PubMed ID: 3263350
[TBL] [Abstract][Full Text] [Related]
20. [Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus].
Kitzis MD; Goldstein FW; Labia R; Acar JF
Ann Microbiol (Paris); 1983; 134A(2):163-8. PubMed ID: 6307103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
